Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2014-01, Vol.28 (1), p.222-225
Hauptverfasser:	Musto, P, Simeon, V, Martorelli, M C, Petrucci, M T, Cascavilla, N, Di Raimondo, F, Caravita, T, Morabito, F, Offidani, M, Olivieri, A, Benevolo, G, Mina, R, Guariglia, R, D'Arena, G, Mansueto, G, Filardi, N, Nobile, F, Levi, A, Falcone, A, Cavalli, M, Pietrantuono, G, Villani, O, Bringhen, S, Omedè, P, Lerose, R, Agnelli, L, Todoerti, K, Neri, A, Boccadoro, M, Palumbo, A
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/67/1059/99 692/699/67/1990/283 Adult Aged Aged, 80 and over Cancer Research Comparative analysis Creatinine Critical Care Medicine Dexamethasone Dexamethasone - administration & dosage Dexamethasone - therapeutic use Drug therapy Female Hematology Humans Hypercalcemia Infections Intensive Internal Medicine letter-to-the-editor Letters to the editor Leukemia Leukemia, Plasma Cell - drug therapy Male Medical prognosis Medicine Medicine & Public Health Middle Aged Oncology Plasma Response rates Thalidomide - administration & dosage Thalidomide - analogs & derivatives Thalidomide - therapeutic use Toxicity Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!